PROSTATIC DISEASES
Clinical trials for PROSTATIC DISEASES explained in plain language.
Never miss a new study
Get alerted when new PROSTATIC DISEASES trials appear
Sign up with your email to follow new studies for PROSTATIC DISEASES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Hard-to-Treat prostate cancer? early trial launches
Disease control Recruiting nowThis study tests a new oral drug called pocenbrodib, alone or with another drug (darolutamide), in 120 men with metastatic castration-resistant prostate cancer (mCRPC). The goal is to find safe doses and see if the combination can slow cancer growth. It is an early-stage trial, s…
Matched conditions: PROSTATIC DISEASES
Phase: PHASE1, PHASE2 • Sponsor: Pathos AI, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Radioactive therapy shows promise for tough prostate cancer
Disease control Recruiting nowThis study tests a new radioactive drug (lutetium rhPSMA-10.1) in men with advanced prostate cancer that has spread and no longer responds to hormone therapy. The goal is to find the safest and most effective dose, and to see if it can shrink tumors or lower PSA levels. About 82 …
Matched conditions: PROSTATIC DISEASES
Phase: PHASE1, PHASE2 • Sponsor: Blue Earth Therapeutics Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC